Cash Flow
• $2.6 million in Cash Receipts from Customers
• In line with the prior Appendix 4C commentary, Q3 FY’22 Net Operating Cash
Outflows increased temporarily to $6.5 million
• Cash Receipts from Customers to steadily increase in Q4 FY’22
• Net Operating Cash Outflows expected to revert to <$3.0 million in Q4 FY’22
note the 4th bullet point that outflows will drop below 3M going fwd.
- Forums
- ASX - By Stock
- Ann: Appendix 4C & Quarterly Activities Report
Cash Flow• $2.6 million in Cash Receipts from Customers• In line...
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $107.2M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.2¢ | $68.49K | 1.292M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 14094 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.052 |
1 | 500000 | 0.051 |
5 | 190000 | 0.050 |
1 | 61000 | 0.049 |
1 | 27812 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 14094 | 1 |
0.054 | 100000 | 1 |
0.055 | 332498 | 2 |
0.056 | 250000 | 1 |
0.058 | 7842 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online